Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.41B |
| 2 |
American Tower
AMT
|
+$272M |
| 3 |
Microsoft
MSFT
|
+$271M |
| 4 |
Zoom
ZM
|
+$245M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.25% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Tarsus Pharmaceuticals
TARS
$2.79B
| $4.56M | ﹤0.01% |
+110,375
| New | +$3.14M |
|
|
AFMD
2652
DELISTED
Affimed
AFMD
| $4.55M | ﹤0.01% |
78,242
+10,291
| +15% | +$485K |
|
2653
Alto Ingredients
ALTO
$349M
| $4.54M | ﹤0.01% |
836,328
+452,060
| +118% | +$3.14M |
|
2654
Crinetics Pharmaceuticals
CRNX
$8.92B
| $4.54M | ﹤0.01% |
321,501
+9,724
| +3% | +$135K |
|
2655
Cytosorbents Corp
CTSO
$24.8M
| $4.53M | ﹤0.01% |
568,407
+41,552
| +8% | +$348K |
|
2656
Plains All American Pipeline
PAA
$16.6B
| $4.52M | ﹤0.01% |
548,116
+522,923
| +2,076% | +$3.98M |
|
2657
Lifecore Biomedical
LFCR
$183M
| $4.51M | ﹤0.01% |
416,182
-14,434
| -3% | -$149K |
|
2658
Kodak
KODK
$928M
| $4.5M | ﹤0.01% |
552,878
+76,995
| +16% | +$642K |
|
2659
AerCap
AER
$24.3B
| $4.5M | ﹤0.01% |
98,665
-538,339
| -85% | -$18.8M |
|
2660
Artesian Resources
ARTNA
$355M
| $4.49M | ﹤0.01% |
121,092
+1,533
| +1% | +$57K |
|
2661
Utah Medical Products
UTMD
$223M
| $4.48M | ﹤0.01% |
53,129
+81
| +0.2% | +$6.91K |
|
2662
Spyre Therapeutics
SYRE
$9.14B
| $4.46M | ﹤0.01% |
22,681
-57
| -0.3% | -$11.8K |
|
|
DSKE
2663
DELISTED
Daseke, Inc. Common Stock
DSKE
| $4.46M | ﹤0.01% |
767,485
-15,735
| -2% | -$100K |
|
2664
VirnetX Holding Corp
VHC
$66.1M
| $4.46M | ﹤0.01% |
44,206
+867
| +2% | +$93.7K |
|
2665
First Internet Bancorp
INBK
$256M
| $4.45M | ﹤0.01% |
154,705
+9,224
| +6% | +$221K |
|
|
HAYN
2666
DELISTED
Haynes International, Inc.
HAYN
| $4.45M | ﹤0.01% |
186,474
-5,423
| -3% | -$113K |
|
|
CMRX
2667
DELISTED
Chimerix, Inc.
CMRX
| $4.44M | ﹤0.01% |
920,063
+16,539
| +2% | +$60K |
|
|
RUBY
2668
DELISTED
Rubius Therapeutics, Inc
RUBY
| $4.43M | ﹤0.01% |
584,132
-22,483
| -4% | -$134K |
|
|
ASAP
2669
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $4.43M | ﹤0.01% |
79,715
+8,160
| +11% | +$525K |
|
2670
Blue Bird Corp
BLBD
$2.14B
| $4.43M | ﹤0.01% |
242,649
+435
| +0.2% | +$6.37K |
|
2671
NWPX Infrastructure Inc
NWPX
$1.18B
| $4.42M | ﹤0.01% |
156,130
+317
| +0.2% | +$8.98K |
|
2672
CleanSpark
CLSK
$3.38B
| $4.4M | ﹤0.01% |
151,599
+50,759
| +50% | +$646K |
|
2673
Amalgamated Financial
AMAL
$1.5B
| $4.38M | ﹤0.01% |
319,159
+66,811
| +26% | +$850K |
|
2674
Atomera
ATOM
$208M
| $4.37M | ﹤0.01% |
271,710
+46,494
| +21% | +$486K |
|
2675
Taysha Gene Therapies
TSHA
$1.83B
| $4.35M | ﹤0.01% |
+163,814
| New | +$3.53M |
|
Similar funds
Geode Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Geode Capital Management held 4,369 positions worth $596B, up 17% from $510B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q4 2020 filing shows 215 new, 3,067 increased, 650 reduced and 100 closed positions. Its largest new stake was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M. The largest sale was Tiffany & Co., an estimated $206M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M.
- Geode Capital Management added most to Tesla in Q4 2020, an estimated $2.41B increase.
- Geode Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $131M.
- Geode Capital Management fully exited Tiffany & Co. in Q4 2020, selling an estimated $206M.
- Geode Capital Management's ten largest holdings make up 22% of its $596B portfolio in Q4 2020.
- Geode Capital Management opened 215 new positions and closed 100 in Q4 2020.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $596B.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.